Pancreatitis after ERCP
Conditions
Interventions
control group:no nasopancreatic tube implantation
Experimental group:nasopancreatic tube implantation
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Aged >= 18 years patients with primary duodenal papilla who received diagnostic or therapeutic ERCP
Exclusion criteria
Exclusion criteria: 1. Patients with previous EST without pancreatic duct operation plan; 2. Patients with ERCP biliary stents pulled out or replaced without pancreatic duct operation plan; 3. Patients with bile duct and duodenal fistula, intubation through biliary and duodenal anastomoses, and biliary jejunostomy; 4. Patients with suspected or confirmed pancreatic cancer (low incidence of PEP); 5. Patients with acute pancreatitis within 3 days before operation; 6. Patients with severe gastroesophageal varices; 7. Patients with severe cardiovascular and cerebrovascular diseases; 8. Patients with mental disorders; 9. Patients who are unwilling or unable to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of pancreatitis after ERCP; | — |
Secondary
| Measure | Time frame |
|---|---|
| moderate and severe incidence of pancreatitis after ERCP; | — |
Countries
China
Contacts
Public ContactWu Qiao
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed